Gufic BioSciences Complete Financial Statements

GUFICBIO • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023

Complete Financial Data Export

Export complete financial statements for Gufic BioSciences (GUFICBIO). Downloads include all available records across all periods. For market performance, see the GUFICBIO stock price today .

Profitability Ratios

Net Profit Margin 7.11% 2025 data
EBITDA Margin 16.74% 2025 data
Operating Margin 16.00% 2025 data
Return on Assets 1.45% 2025 data
Return on Equity 2.83% 2025 data

Balance Sheet Ratios

Current Ratio 3.45 2025 data
Debt to Equity 1.95 2025 data
Equity Ratio 51.41% 2025 data
Asset Turnover 0.20 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+17.2%
Year-over-Year
Net Profit Growth
-22.7%
Year-over-Year
EBITDA Growth
+2.6%
Year-over-Year
Expense Growth
+19.9%
Year-over-Year
Assets Growth
+7.0%
Year-over-Year
Equity Growth
+12.8%
Year-over-Year
Liabilities Growth
+7.0%
Year-over-Year
Operating Cash Flow Growth
+1637.5%
Year-over-Year
Investing Cash Flow Growth
+30.4%
Year-over-Year
Financing Cash Flow Growth
-145.1%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Jun 2023 Dec 2023
Revenue 239 205 225 204 196 204 210 215 196 202
Expenses 199 179 190 166 161 167 174 176 159 165
EBITDA 40 27 34 39 35 37 36 40 36 37
Operating Profit Margin % 16.00% 13.00% 15.00% 19.00% 18.00% 18.00% 16.00% 18.00% 18.00% 18.00%
Depreciation 8 8 8 4 4 4 5 4 4 4
Interest 10 8 9 5 4 5 5 5 4 3
Profit Before Tax 23 11 17 29 27 28 26 31 28 30
Tax 6 3 4 8 7 7 7 8 7 7
Net Profit 17 8 13 22 20 21 19 23 21 22
Earnings Per Share (₹) 1.68 0.77 1.30 2.17 2.00 2.08 1.93 2.39 2.13 2.23

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 1,169 1,093
Current Assets 625 601
Fixed Assets 506 159
Capital Work in Progress 22 307
Investments 2 2
Other Assets 640 625
LIABILITIES
Total Liabilities 1,169 1,093
Current Liabilities 181 188
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 601 533
Share Capital 10 10
Reserves & Surplus 591 523

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities 123 -8
Investing Activities -71 -102
Financing Activities -37 82
Net Cash Flow 15 -28